COLL – collegium pharmaceutical, inc. (US:NASDAQ)
Stock Stats
News
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings.
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? [Yahoo! Finance]
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings.
Collegium to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Form 4 COLLEGIUM PHARMACEUTICAL For: Nov 12 Filed by: Karnani Vikram
Form 4 COLLEGIUM PHARMACEUTICAL For: Nov 12 Filed by: Fallon John A.
Form SCHEDULE 13G COLLEGIUM PHARMACEUTICAL Filed by: RENAISSANCE TECHNOLOGIES LLC
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Fallon John A.
Form 4 COLLEGIUM PHARMACEUTICAL For: Nov 06 Filed by: Tupper Colleen
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.